Vivani Medical, Inc. (VANI)

NASDAQ: VANI · IEX Real-Time Price · USD
2.43
-0.14 (-5.45%)
At close: Sep 23, 2022 4:00 PM
2.42
-0.01 (-0.41%)
After-hours: Sep 23, 2022 5:59 PM EDT
-5.45%
Market Cap 31.92M
Revenue (ttm) n/a
Net Income (ttm) -9.07M
Shares Out 13.14M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Aug 19, 2022
Volume 128,112
Open 2.60
Previous Close 2.57
Day's Range 2.28 - 2.60
52-Week Range 2.28 - 10.80
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About VANI

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. [Read more...]

Industry Medical Devices
IPO Date Nov 19, 2014
Employees 12
Stock Exchange NASDAQ
Ticker Symbol VANI
Full Company Profile

Financial Performance

Financial Statements

News

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc., formerly Second Sight Medical, Inc., (NASDAQ: VANI) (the “Company” or “Vivani”) announced that trading of the Company's common stock on The Nas...

3 weeks ago - Business Wire

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name ...

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc.(NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an ar...

3 weeks ago - Business Wire

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, I...

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 month ago - Business Wire

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an ar...

2 months ago - Business Wire

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S...

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview ...

5 months ago - Business Wire

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Second Sight Medical Products, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - February 18, 2022) - Rigrodsky Law, P.A. announces that it is investigating Second Sight Medical Products, Inc. ("Second Sight") (NASDAQ: EYES) regarding possible...

7 months ago - Newsfile Corp

SECOND SIGHT MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates ...

NEW ORLEANS, Feb. 16, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

7 months ago - PRNewsWire

EYES Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Second Sight Medical Products, Inc....

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Second Sight Medical Products, Inc. (NASDAQ: EYES) and Nano Precision Medical, Inc. is fa...

7 months ago - Business Wire

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.

EYES stock is up 15% today on news that Second Sight Medical is making a strategic acquisition. Here's what to know.

7 months ago - InvestorPlace

Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical

Second Sight Medical Products Inc (NASDAQ: EYES) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction.  Second Sight Medical develops implantable visual prosthetics.

Other symbols: AZN
7 months ago - Benzinga

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Impl...

LOS ANGELES & EMERYVILLE, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that the...

7 months ago - Business Wire

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 year ago - Business Wire

EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight

EYES stock is set for another day of double-digit gains after the European patent agency approved the company's application. The post EYES Stock: The Artificial Vision News That Has Investors Looking at...

1 year ago - InvestorPlace

Second Sight Medical Products Announces Closing of Public Offering

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 year ago - Business Wire

Second Sight Medical Products Announces Pricing of Public Offering

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 year ago - Business Wire

Second Sight Medical Products Announces Proposed Public Offering of Common Stock

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to create an ar...

1 year ago - Business Wire

Second Sight Medical Products Announces Results of its 2021 Annual Meeting

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 year ago - Business Wire

Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an a...

1 year ago - Business Wire

Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today

Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...

Other symbols: LHDXRMED
1 year ago - Benzinga

What To Watch For As Second Sight Stock Gaps Higher On Vision Study Results

Second Sight Medical Products Inc. (NASDAQ: EYES) shares gapped up Wednesday morning following the two-year results from the company's Orion Study in visual prosthetics.  Four out of five patients are a...

1 year ago - Benzinga

Second Sight Medical Products Announces Two-Year Results of its Orion Study

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended t...

1 year ago - Business Wire

5 Heavily Shorted Stocks to Watch Carefully

Short-covering has become one of the hottest buzzwords of the year. Here are 5 stocks with some of the highest shorts on the market.

Other symbols: BLNKFUVOTRKROOT
1 year ago - InvestorPlace

Most Shorted Stocks: Could EYES, BLNK, DISCA or CLVS Be the Next GameStop?

Investors are clamoring to find the next GameStop. Of the most shorted stocks right now, these are the candidates most primed for a squeeze.

Other symbols: AMCBLNKCHPT
1 year ago - InvestorPlace

Second Sight Medical Products Names Dean Baker and Alexandra Larson to its Board of Directors

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended t...

1 year ago - Business Wire

Termination of the business combination with Second Sight Medical Products, Inc.

Termination of the business combination with Second Sight Medical Products, Inc.

1 year ago - GlobeNewsWire